Лучшие больницы для «Carpal Tunnel Syndrome Treatment» в Ченнаи, Индия

Carpal Tunnel Syndrome is a compressive median neuropathy caused by elevated intracarpal tunnel pressure—normally 2–10 mmHg at rest—which, when chronically elevated above 20–30 mmHg, impairs axonal transport and myelin integrity along the median nerve. The resultant ischemic and mechanical injury produces the hallmark constellation of nocturnal paraesthesias, thenar wasting, diminished two-point discrimination, and progressive grip weakness in the lateral 3½ digits. Left untreated, demyelination advances to Wallerian axonal degeneration, converting a fully reversible condition into one with permanent sensorimotor deficit.

• Confirmed median neuropathy on electrodiagnostic testing (NCV/EMG) with distal sensory latency > 3.5 ms or distal motor latency > 4.5 ms
• Clinical staging: mild to severe CTS unresponsive to ≥ 6 weeks of conservative management (neutral-position splinting, corticosteroid injection)
• Thenar muscle wasting or objective loss of two-point discrimination (> 6 mm static), indicating advanced nerve compromise warranting urgent surgical referral
• Occupational or lifestyle-related CTS (prolonged keyboard use, vibratory tool exposure, repetitive flexion-extension work) in patients who have failed ergonomic modification
• Secondary CTS associated with systemic conditions: rheumatoid arthritis, hypothyroidism, diabetes mellitus, acromegaly, amyloidosis, pregnancy-related—with the underlying condition optimally managed pre-operatively
• +1 more

Required Pre-operative Diagnostics:

• Nerve Conduction Studies (NCS) + EMG — mandatory severity stratification and surgical planning
• High-resolution median nerve ultrasound — cross-sectional area measurement, synovial hypertrophy assessment
• Full blood count, HbA1c, thyroid function panel (TSH/Free T4) — to detect contributing systemic pathology
• Coagulation profile (PT/INR/aPTT) — pre-anaesthesia requirement
• ECG and physician clearance for patients > 50 years or with cardiovascular comorbidities

**1. Conservative (Non-Surgical) Management** Indicated for mild-to-moderate CTS, pregnancy-related CTS, or patients unfit for surgery. The primary intervention is a custom-moulded or prefabricated wrist orthosis worn in the neutral (0°) position, particularly at night, reducing intracarpal pressure to physiological levels during sleep. A single ultrasound-guided corticosteroid injection (methylprednisolone 40 mg or triamcinolone 20–40 mg with 1% lidocaine) delivers superior depot placement versus landmark-guided technique and provides meaningful symptom relief for 2–4 months in up to 80% of patients, serving as a useful bridge or diagnostic-therapeutic tool. Oral anti-inflammatory agents, B6 supplementation (evidence limited), and structured hand therapy / ergonomic retraining complement immobilisation. Iontophoresis and low-level laser therapy are adjunctive modalities with emerging supportive data.

**2. Open Carpal Tunnel Release (OCTR)** The gold-standard surgical technique with the longest safety record. Under local anaesthesia with intravenous sedation or regional Bier block (lignocaine 0.5%), a 2–4 cm longitudinal incision is made along the thenar crease ulnar to the recurrent motor branch of the median nerve. The transverse carpal ligament is divided under direct vision, with optional internal neurolysis and synovectomy in revision or inflammatory cases. Advantages include complete ligament division under direct visualisation, suitability for complex or recurrent cases, and the lowest rate of incomplete release (< 1%). The main disadvantage versus endoscopic technique is a slightly longer scar tenderness and return-to-work timeline.

**3. Endoscopic Carpal Tunnel Release (ECTR)** The minimally invasive standard, available in two validated systems: single-portal (Agee) and dual-portal (Chow). A 1–2 cm proximal incision admits the endoscope into Guyon's canal plane; the transverse carpal ligament is divided from inside out using a retractable blade under camera visualisation on a high-definition monitor. ECTR delivers equivalent long-term outcomes to OCTR with statistically significant advantages: smaller scar, reduced pillar pain, faster return to work (mean 2 weeks versus 4–6 weeks for OCTR), and lower short-term morbidity. It is the preferred technique in GAF Healthcare-partnered centres in India and the UAE for straightforward primary CTS.

**4. Ultrasound-Guided Percutaneous Needle Release (UPNR / Hydrodissection)** An office-based, needle-only technique where a bevelled needle is used under real-time ultrasound guidance to serially release the transverse carpal ligament fascicles while simultaneously performing hydrodissection of the median nerve from surrounding scar or tenosynovium. Evidence from randomised trials (2019–2023) shows non-inferiority to OCTR for mild-to-moderate CTS at 6 months, with near-zero downtime. Not yet universally adopted but available at select tertiary centres affiliated with GAF Healthcare.

**Phase 1 — Pre-Arrival (2–4 Weeks Before Travel)**

GAF Healthcare's medical coordination team reviews NCV/EMG reports, clinical photographs, and medical history submitted via the patient portal. A board-certified hand surgeon at the designated partner hospital conducts a telemedicine consultation to confirm candidacy, finalise the surgical approach, and issue the treatment plan and cost estimate. Pre-travel investigations are advised (blood work, ECG if indicated) to avoid delays on arrival. Medical visa documentation (India) or entry authorisation (UAE) is processed concurrently.

**Phase 2 — Arrival & Pre-operative Assessment (Day 1)**